Belatacept and non-melanoma skin cancer risk in kidney transplant recipients: a narrative review from a mechanistic and clinical perspective
Abstract Non-melanoma skin cancer is a prevalent complication in renal transplant recipients due to long-term immunosuppressive therapy. Calcineurin inhibitors, such as tacrolimus and cyclosporine, are effective in preventing graft rejection; however, they significantly increase the risk of non-mela...
Saved in:
| Main Authors: | Hany M. El Hennawy, Omar Safar, Ahmed Nassar, Mahmoud Z. El Madawie, Mohammad F. Zaitoun, Yasser M. Almahdi, Abdullah S. Al Faifi, Ibrahim Tawhari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Nephrology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12882-025-04373-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of belatacept in kidney transplantation
by: N. N. Babenko, et al.
Published: (2018-09-01) -
Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients
by: Orhan Efe, et al.
Published: (2024-12-01) -
One-Year Outcomes After Belatacept Conversion in Adolescent Kidney Transplant Recipients
by: Charlotte Duneton, et al.
Published: (2025-06-01) -
Similar Efficacy in Belatacept-Converted Kidney Transplant Recipients With Steroid-Avoiding Regimen
by: Nathalie Chavarot, et al.
Published: (2025-03-01) -
BELATACEPT IN RENAL TRANSPLANTATION
by: A. I. Sushkov, et al.
Published: (2013-03-01)